Jean‐Jacques Serrano

599 total citations
36 papers, 485 citations indexed

About

Jean‐Jacques Serrano is a scholar working on Inorganic Chemistry, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Jean‐Jacques Serrano has authored 36 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Inorganic Chemistry, 10 papers in Molecular Biology and 6 papers in Clinical Biochemistry. Recurrent topics in Jean‐Jacques Serrano's work include Vanadium and Halogenation Chemistry (14 papers), Metabolism and Genetic Disorders (4 papers) and Cassava research and cyanide (4 papers). Jean‐Jacques Serrano is often cited by papers focused on Vanadium and Halogenation Chemistry (14 papers), Metabolism and Genetic Disorders (4 papers) and Cassava research and cyanide (4 papers). Jean‐Jacques Serrano collaborates with scholars based in France, Canada and Sweden. Jean‐Jacques Serrano's co-authors include John H. McNeill, G. Cros, Gérard Cros, Sasanka Ramanadham, Margaret C. Cam, René Lazaro, Gérard Ribes, M. Souli, Mirosław Krośniak and Karine Portet and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Jean‐Jacques Serrano

33 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Jacques Serrano France 13 267 197 92 74 35 36 485
J.H. McNeill Canada 11 180 0.7× 164 0.8× 70 0.8× 158 2.1× 18 0.5× 17 509
G. Cros France 13 295 1.1× 289 1.5× 125 1.4× 95 1.3× 21 0.6× 44 841
Eriko Ueda Japan 12 289 1.1× 120 0.6× 184 2.0× 44 0.6× 16 0.5× 18 581
Soter Dai Hong Kong 14 73 0.3× 161 0.8× 64 0.7× 132 1.8× 101 2.9× 41 554
Mary L. Battell Canada 15 325 1.2× 229 1.2× 346 3.8× 144 1.9× 12 0.3× 23 911
John H. McNeill Canada 11 185 0.7× 243 1.2× 120 1.3× 172 2.3× 8 0.2× 19 784
S. Dai Hong Kong 13 90 0.3× 108 0.5× 65 0.7× 78 1.1× 64 1.8× 33 398
Arun G. Tahiliani United States 14 543 2.0× 517 2.6× 191 2.1× 182 2.5× 23 0.7× 20 1.2k
H. Hannemann Germany 8 90 0.3× 161 0.8× 38 0.4× 57 0.8× 27 0.8× 12 344
Heber Amilcar Martins Brazil 12 186 0.7× 125 0.6× 108 1.2× 81 1.1× 7 0.2× 15 464

Countries citing papers authored by Jean‐Jacques Serrano

Since Specialization
Citations

This map shows the geographic impact of Jean‐Jacques Serrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Jacques Serrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Jacques Serrano more than expected).

Fields of papers citing papers by Jean‐Jacques Serrano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Jacques Serrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Jacques Serrano. The network helps show where Jean‐Jacques Serrano may publish in the future.

Co-authorship network of co-authors of Jean‐Jacques Serrano

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Jacques Serrano. A scholar is included among the top collaborators of Jean‐Jacques Serrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Jacques Serrano. Jean‐Jacques Serrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serrano, Jean‐Jacques, et al.. (2015). Role of Catecholamines in Nervous System Development: Effects of Prenatal 6-Hydroxydopa Treatment on Behaviour and Brain Structures1. Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences. 9. 11–19.
2.
Azay, Jacqueline, J. Brès, Mirosław Krośniak, et al.. (2001). Vanadium pharmacokinetics and oral bioavailability upon single‐dose administration of vanadyl sulfate to rats. Fundamental and Clinical Pharmacology. 15(5). 313–324. 19 indexed citations
3.
Cros, Gérard, et al.. (2001). Estimation of pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in beagle dogs. European Journal of Pharmaceutical Sciences. 14(4). 323–329. 17 indexed citations
4.
Portet, Karine, et al.. (1999). Vasopressin V2 (SR121463A) and V1a (SR49059) receptor antagonists both inhibit desmopressin vasorelaxing activity. European Journal of Pharmacology. 383(3). 287–290. 11 indexed citations
5.
Grigorescu, Florin, et al.. (1997). Characterization of Vanadyl Sulfate Effect on Vascular Contraction: Roles of Calcium and Tyrosine Phosphorylation. Journal of Pharmacology and Experimental Therapeutics. 281(1). 491–498. 12 indexed citations
6.
Gross, R., Patrick Poucheret, Pellegrino Masiello, et al.. (1996). Vanadyl sulphate differently influences insulin response to glucose in isolated pancreas of normal rats after in vivo or in vitro exposure. European Journal of Pharmacology. 318(1). 145–151. 9 indexed citations
7.
Poucheret, Patrick, et al.. (1995). Long-term correction of STZ-diabetic rats after short-term i.p. VOSO4 treatment: Persistence of insulin secreting capacities assessed by isolated pancreas studies. Molecular and Cellular Biochemistry. 153(1-2). 197–204. 10 indexed citations
8.
Cros, Gérard, Margaret C. Cam, Jean‐Jacques Serrano, Gérard Ribes, & John H. McNeill. (1995). Long-term antidiabetic activity of vanadyl after treatment withdrawal: Restoration of insulin secretion?. Molecular and Cellular Biochemistry. 153(1-2). 191–195. 9 indexed citations
9.
10.
11.
Cam, Margaret C., Gérard Cros, Jean‐Jacques Serrano, René Lazaro, & John H. McNeill. (1993). In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes. Diabetes Research and Clinical Practice. 20(2). 111–121. 47 indexed citations
12.
13.
14.
Cros, G., et al.. (1990). Toxicological Aspects of Vanadyl Sulphate on Diabetic Rats: Effects on Vanadium Levels and Pancreatic B‐Cell Morphology. Pharmacology & Toxicology. 67(3). 192–198. 82 indexed citations
15.
Ramanadham, Sasanka, et al.. (1990). Enhanced in vivo sensitivity of vanadyl-treated diabetic rats to insulin. Canadian Journal of Physiology and Pharmacology. 68(4). 486–491. 58 indexed citations
16.
Cros, Gérard, et al.. (1989). Short- and long-term effects of reserpine on rat cardiac beta-adrenoceptors. General Pharmacology The Vascular System. 20(3). 277–284. 3 indexed citations
17.
Cros, G., et al.. (1988). Diabetes-induced rat tracheal segment supersensitivity to carbachol. Canadian Journal of Physiology and Pharmacology. 66(5). 660–662. 9 indexed citations
18.
Cros, Gérard, et al.. (1988). Post-natal evolution of rat cardiac beta-adrenoceptors. Life Sciences. 43(8). 699–706. 18 indexed citations
19.
Warnet, Jean‐Michel, et al.. (1987). Effects of Subchronic Low-Protein Diet on Some Tissue Glutathione - Related Enzyme Activities in the Rat. PubMed. 11. 45–49. 3 indexed citations
20.
Cros, Gérard, Jean‐Jacques Serrano, & John H. McNeill. (1981). The effect of trypsin on rate, force and cyclic AMP in guinea pig atria. European Journal of Pharmacology. 74(1). 95–99. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.H. McNeill Breakdown of academic impact, for papers by G. Cros Breakdown of academic impact, for papers by Eriko Ueda Breakdown of academic impact, for papers by Soter Dai Breakdown of academic impact, for papers by Mary L. Battell Breakdown of academic impact, for papers by John H. McNeill Breakdown of academic impact, for papers by S. Dai Breakdown of academic impact, for papers by Arun G. Tahiliani Breakdown of academic impact, for papers by H. Hannemann Breakdown of academic impact, for papers by Heber Amilcar Martins
Rankless by CCL
2026